Ross Muken Biography and Net Worth

President of SOPHiA GENETICS

Ross Muken, B.Sc., is a seasoned executive with more than 20 years of experience across life sciences, health technology, medical devices, and pharma services. Ross joined SOPHiA GENETICS in February 2021 as Chief Financial Officer, and in March 2023 was appointed, Chief Financial Officer & Chief Operating Officer.  In November 2024, Ross was appointed President.

Before joining SOPHiA GENETICS, he was CFO & COO of Click Therapeutics.

Prior to that, he was partner, Senior Managing Director and head of the healthcare services & technology equity research team at Evercore/ISI Group, where he covered more than 50 companies across the healthcare technology & distribution, life science tools & diagnostics, managed care & facilities and medical supplies & devices subsectors.

Earlier in his career, Ross served as Senior Managing  Director at Deutsche Bank Securities and was part of the equity research division at Thomas Weisel Partners. His professional journey began as an M&A investment banker at Bank of America Securities after graduating from Boston University magna cum laude with a B.Sc. in business administration.

What is Ross Muken's net worth?: The estimated net worth of Ross Muken is at least $3.62 million as of April 20th, 2026. Muken owns 681,672 shares of SOPHiA GENETICS stock worth more than $3,616,270 as of May 4th. This net worth evaluation does not reflect any other assets that Muken may own. Learn More about Ross Muken's net worth.
How do I contact Ross Muken?: The corporate mailing address for Muken and other SOPHiA GENETICS executives is , , . SOPHiA GENETICS can also be reached via phone at 41-21-694-1060. Learn More on Ross Muken's contact information.
Has Ross Muken been buying or selling shares of SOPHiA GENETICS?: In the last ninety days, Ross Muken has sold $90,808.07 in shares of SOPHiA GENETICS stock. Most recently, Ross Muken sold 760 shares of the business's stock in a transaction on Monday, April 20th. The shares were sold at an average price of $5.20, for a transaction totalling $3,952.00. Following the completion of the sale, the president now directly owns 681,672 shares of the company's stock, valued at $3,544,694.40. Learn More on Ross Muken's trading history.
Who are SOPHiA GENETICS's active insiders?: SOPHiA GENETICS's insider roster includes Jurgi Camblong (Founder and CEO), George Cardoza (EVP – Chief Financial Officer), Philippe Menu (Insider), Ross Muken (President), Kevin Puylaert (SVP, Chief Sales Officer), Manuela Valente (Insider), and Abhimanyu Verma (EVP, Chief Technology Officer). Learn More on SOPHiA GENETICS's active insiders.
Are insiders buying or selling shares of SOPHiA GENETICS?: In the last twelve months, insiders at the sold shares 57 times. They sold a total of 193,859 shares worth more than $943,777.03. The most recent insider tranaction occured on April, 27th when insider Philippe Menu sold 5,000 shares worth more than $24,100.00. Insiders at SOPHiA GENETICS own 4.9% of the company. Learn More about insider trades at SOPHiA GENETICS.
Information on this page was last updated on 4/27/2026.

Ross Muken Insider Trading History at SOPHiA GENETICS

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/20/2026	Sell	760	$5.20	$3,952.00	681,672
4/14/2026	Sell	2,800	$4.96	$13,888.00	682,432
4/13/2026	Sell	4,442	$4.76	$21,143.92	685,232
4/10/2026	Sell	3,687	$4.69	$17,292.03	689,674
4/9/2026	Sell	1,950	$4.74	$9,243.00	693,361
4/8/2026	Sell	2,786	$4.84	$13,484.24	695,311
4/7/2026	Sell	2,424	$4.87	$11,804.88	698,097
3/19/2026	Sell	1,183	$4.79	$5,666.57	271,910

Ross Muken Buying and Selling Activity at SOPHiA GENETICS

SOPHiA GENETICS Company Overview

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

Today's Range

Now: $5.29

$5.15

$5.45

50 Day Range

MA: $4.81

$4.10

$5.28

2 Week Range

Now: $5.29

$2.59

$5.70

Volume

42,616 shs

Average Volume

167,594 shs

Market Capitalization

$362.31 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.01